WestEnd Advisors’s Colgate-Palmolive CL Stock Holding History

WestEnd Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.9K	Hold	34	–	–	﹤0.01%	130
2025 Q4	$2.69K	Hold	34	–	–	﹤0.01%	136
2025 Q3	$2.72K	Buy	34 +5	+17%	+$427	﹤0.01%	135
2025 Q2	$2.64K	Sell	29 -2	-6%	-$183	﹤0.01%	134
2025 Q1	$2.9K	Buy	31 +21	+210%	+$1.88K	﹤0.01%	130
2024 Q4	$909	Buy	10 +1	+11%	+$95	﹤0.01%	139
2024 Q3	$934	Buy	9 +2	+29%	+$204	﹤0.01%	131
2024 Q2	$679	Hold	7	–	–	﹤0.01%	142
2024 Q1	$630	Sell	7 -6	-46%	-$508	﹤0.01%	138
2023 Q4	$1.04K	Hold	13	–	–	﹤0.01%	114
2023 Q3	$924	Buy	+13	New	+$972	﹤0.01%	116
2023 Q1	–	Sell	-10	Closed	-$744	–	114
2022 Q4	$788	Buy	10 +2	+25%	+$150	﹤0.01%	112
2022 Q3	$1K	Buy	+8	New	+$627	﹤0.01%	102

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

WestEnd Advisors's CL Position: Q1 2026 in Review

WestEnd Advisors held its Colgate-Palmolive (CL) position steady in Q1 2026 at 34 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #130.

WestEnd Advisors first reported a position in CL in Q3 2022 and has held it in 13 quarters since. The position peaked at $2.9K in Q1 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

WestEnd Advisors held 34 shares of Colgate-Palmolive worth $2.9K as of Q1 2026.
WestEnd Advisors left its Colgate-Palmolive share count unchanged in Q1 2026.
Colgate-Palmolive made up ﹤0.01% of WestEnd Advisors's portfolio in Q1 2026, its #130 holding.
WestEnd Advisors first reported a position in Colgate-Palmolive in Q3 2022 and has held it in 13 quarters since.
WestEnd Advisors's Colgate-Palmolive position peaked at $2.9K in Q1 2025.
1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on WestEnd Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.